Advantages of multi-arm non-randomised sequentially allocated cohort designs for Phase II oncology trials. (2022)

First Author: Mossop H
Attributed to:  Development of a 'humanised' model for renal cancer funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1038/s41416-021-01613-5

PubMed Identifier: 34750494

Publication URI: http://europepmc.org/abstract/MED/34750494

Type: Journal Article/Review

Volume: 126

Parent Publication: British journal of cancer

Issue: 2

ISSN: 0007-0920